1. Home
  2. FNWB vs ACET Comparison

FNWB vs ACET Comparison

Compare FNWB & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.98

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$0.50

Market Cap

93.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
ACET
Founded
1923
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
93.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
FNWB
ACET
Price
$9.98
$0.50
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$13.50
$8.50
AVG Volume (30 Days)
31.1K
2.3M
Earning Date
01-28-2026
11-05-2025
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
N/A
Revenue This Year
$31.86
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.47
N/A
52 Week Low
$6.05
$0.45
52 Week High
$12.10
$1.11

Technical Indicators

Market Signals
Indicator
FNWB
ACET
Relative Strength Index (RSI) 65.97 33.12
Support Level $9.80 $0.50
Resistance Level $10.14 $0.59
Average True Range (ATR) 0.20 0.05
MACD -0.04 0.00
Stochastic Oscillator 53.85 4.30

Price Performance

Historical Comparison
FNWB
ACET

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: